Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating denosumab and Actonel (risedronate) in postmenopausal osteoporosis patients transitioned from alendronate therapy has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Actonel (risedronate)
• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2012-12-12